We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Newly Characterized Toxin-Antitoxin Module May Lead to Improved Antibiotics

By LabMedica International staff writers
Posted on 13 Dec 2011
An international team of molecular microbiologists has detailed the molecular pathway responsible for a toxin-antitoxin system in Escherichia coli that becomes activated when the bacteria are put under stress.

A toxin-antitoxin system is a set of two or more closely linked genes that together encode both a protein “poison” and a corresponding “antidote.” When these systems are contained on plasmids, they ensure that only the daughter cells that inherit the plasmid survive after cell division. More...
If the plasmid is absent in a daughter cell, the unstable antitoxin is degraded and the stable toxic protein kills the new cell.

MazEF, a toxin-antitoxin locus found in E. coli and other bacteria, induces programmed cell death in response to starvation, specifically a lack of amino acids. This releases the cell's contents for absorption by neighboring cells, potentially preventing the death of close relatives, and thereby increasing the inclusive fitness of the cell that perished. The toxin portion MazF is an endoribonuclease that cleaves single-stranded mRNAs at ACA (adenine-cytosine-adenine) sequences.

Investigators at the Hebrew University of Jerusalem (Israel) and the University of Vienna (Austria) reported in the September 30, 2011, issue of the journal Cell that MazF cleaved RNA molecules at ACA sites at or closely upstream of the AUG (adenine-uracil- guanine) start codon of some specific mRNAs and thereby generated leaderless mRNAs. Moreover, MazF also targeted 16S rRNA within 30S ribosomal subunits at the decoding center, thereby removing 43 nucleotides from the 3-prime terminus. As this region comprises the anti-Shine-Dalgarno (aSD) sequence that is required for translation initiation on canonical mRNAs, a subpopulation of ribosomes is formed that selectively translates the described leaderless mRNAs both in vivo and in vitro.

The characterization of this particular toxin-antitoxin module may lead to new approaches to the design of improved, novel antibiotics that would effectively utilize the stress-inducing mechanism process in order to destroy more efficiently pathogenic bacteria.

Related Links:

Hebrew University of Jerusalem
University of Vienna



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
New
Gold Member
Platelet Function Analyzer
AGGRENG-40
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers identified 157 metabolites linked to BBB damage, including 25 that appeared in at least two independent studies (Image Credit: Adobe Stock)

Blood Metabolite Patterns May Enable Early Detection of Blood-Brain Barrier Injury

Early injury to the blood-brain barrier (BBB) can precede many neurological disorders but remains difficult to detect noninvasively. Laboratory markers that identify barrier dysfunction before symptoms... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.